跳至主要内容
临床试验/NCT00440570
NCT00440570已完成早期 1 期

Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe

Pasche, Boris, M.D.2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2004年10月1日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
2
试验地点
2
主要终点
Safety of daily administration of amplitude-modulated electromagnetic fields in patients with advanced cancer

研究概览

简要总结

In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression.

详细描述

Background: In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a portable and programmable device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment.

Methods: We will conducted a feasibility study consisting of three daily treatments. All patients with advanced solid tumors and measurable disease will be eligible, irrespective of prior treatments. Patients will be assessed with laboratory exams (complete blood count, comprehensive profile, tumor markers), imaging studies every other month for the first six months, every third month thereafter.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Advanced tumor that is either metastatic or inoperable

排除标准

  • Pregnancy,
  • Other simultaneous anticancer therapies,
  • ECOG performance status less than 3

结局指标

主要结局

Safety of daily administration of amplitude-modulated electromagnetic fields in patients with advanced cancer

次要结局

  • Complete blood count, comprehensive chemistry profile, tumor markers
  • Tumor assessment as per RECIST criteria

研究者

发起方
Pasche, Boris, M.D.
申办方类型
Indiv

研究点 (2)

Loading locations...

相似试验